Skip to main content

Table 3 Survival analysis

From: Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours

Variable

Relapse-free survival

5 years-RFS (%)

HR (95% CI)

p value

A. Univariate analysis

Histology

 NS

59.1

4.8 (1.4–16.3)

0.012

 Seminoma

90.3

1

 

Age

 ≤30

61.5

2.5 (1–6.5)

0.056

 >30

83.3

1

 

LVI

 Yes

54.5

3.2 (1.3–8.2)

0.014

 No

83.0

1

 

Tumor size (cm)

 ≥4

57.1

4.5 (1.5–13.5)

0.008

 <4

87.9

1

 

Rete testis invasion

 Yes

54.5

4.5 (1.5–13.3)

0.006

 No

88.4

1

 

Epididymis invasion

 Yes

25.0

3.6 (1.4–9.3)

0.008

 No

81.3

1

 

hMLH1 expression

 Null/low

66.7

2 (0.7–5.7)

0.178

 Normal

79.3

1

 

hMSH2 expression

 Null/low

81.3

0.66 (0.2–2.3)

0.524

 Normal

70.0

1

 

EGFR expression

 Positive

52.9

3.5 (1.3–9.8)

0.016

 Negative

82.1

1

 

Variable

Relapse-free survival

 

HR (95% CI)

p value

B. Multivariate analysis

Histology

 NS

 

ns

 Seminoma

  

Age

 ≤30

 

ns

 >30

  

LVI

 Yes

 

ns

 No

  

Tumor size (cm)

 ≥4 

 

ns

 <4 

  

Rete testis invasion

 Yes

 

ns

 No

  

Epididymis invasion

 Yes

7.6 (2.4–23.7)

0.001

 No

1

 

EGFR expression

 Positive

 

ns

 Negative